Yohan Royer

732 total citations
9 papers, 589 citations indexed

About

Yohan Royer is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Yohan Royer has authored 9 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Yohan Royer's work include Cytokine Signaling Pathways and Interactions (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (2 papers). Yohan Royer is often cited by papers focused on Cytokine Signaling Pathways and Interactions (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (2 papers). Yohan Royer collaborates with scholars based in Belgium, United States and France. Yohan Royer's co-authors include Stefan N. Constantinescu, Judith Staerk, Pierre J. Courtoy, Marcel Costuleanu, Virginie Moucadel, Shyam S. Krishnakumar, Katharina F. Kubatzky, Steven O. Smith, Tekla Hornakova and Jean‐Christophe Renauld and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Molecular Cell.

In The Last Decade

Yohan Royer

9 papers receiving 579 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yohan Royer Belgium 9 301 282 250 226 107 9 589
Mahnaz Paktinat United States 6 337 1.1× 616 2.2× 138 0.6× 432 1.9× 110 1.0× 8 929
Stéphanie Dumon United Kingdom 15 116 0.4× 435 1.5× 307 1.2× 300 1.3× 204 1.9× 17 829
Jennifer Lauchle United States 13 181 0.6× 512 1.8× 203 0.8× 243 1.1× 80 0.7× 23 833
Rita Andraos Switzerland 6 120 0.4× 282 1.0× 129 0.5× 98 0.4× 43 0.4× 7 411
Ellen Wei Canada 10 176 0.6× 425 1.5× 156 0.6× 250 1.1× 99 0.9× 26 664
Mie Uchida Japan 10 112 0.4× 327 1.2× 176 0.7× 230 1.0× 92 0.9× 13 566
Louise Barys Switzerland 8 80 0.3× 328 1.2× 157 0.6× 139 0.6× 37 0.3× 12 575
Frédéric Gilles United States 12 202 0.7× 375 1.3× 300 1.2× 124 0.5× 81 0.8× 21 753
Lourdes Mendez United States 10 112 0.4× 309 1.1× 218 0.9× 104 0.5× 190 1.8× 34 609
Jennifer Macaluso United States 8 60 0.2× 350 1.2× 170 0.7× 132 0.6× 75 0.7× 9 539

Countries citing papers authored by Yohan Royer

Since Specialization
Citations

This map shows the geographic impact of Yohan Royer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohan Royer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohan Royer more than expected).

Fields of papers citing papers by Yohan Royer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohan Royer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohan Royer. The network helps show where Yohan Royer may publish in the future.

Co-authorship network of co-authors of Yohan Royer

This figure shows the co-authorship network connecting the top 25 collaborators of Yohan Royer. A scholar is included among the top collaborators of Yohan Royer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohan Royer. Yohan Royer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Pecquet, C., Carmen C. Diaconu, Judith Staerk, et al.. (2012). Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes. Blood. 119(20). 4625–4635. 41 indexed citations
2.
Hornakova, Tekla, Judith Staerk, Yohan Royer, et al.. (2009). Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers. Journal of Biological Chemistry. 284(11). 6773–6781. 54 indexed citations
3.
Hornakova, Tekla, Yohan Royer, Laurent Knoops, et al.. (2008). Ligand-independent Homomeric and Heteromeric Complexes between Interleukin-2 or -9 Receptor Subunits and the γ Chain. Journal of Biological Chemistry. 283(48). 33569–33577. 23 indexed citations
4.
Wernig, Gerlinde, Mamatha M. Reddy, Christoph Walz, et al.. (2008). The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes. Blood. 111(7). 3751–3759. 116 indexed citations
5.
Knoops, L., Tekla Hornakova, Yohan Royer, Stefan N. Constantinescu, & Jean‐Christophe Renauld. (2007). JAK kinases overexpression promotes in vitro cell transformation. Oncogene. 27(11). 1511–1519. 34 indexed citations
6.
Staerk, Judith, Anders Kallin, Yohan Royer, et al.. (2006). JAK2, the JAK2 V617F mutant and cytokine receptors. Pathologie Biologie. 55(2). 88–91. 21 indexed citations
7.
Royer, Yohan, Judith Staerk, Marcel Costuleanu, Pierre J. Courtoy, & Stefan N. Constantinescu. (2005). Janus Kinases Affect Thrombopoietin Receptor Cell Surface Localization and Stability. Journal of Biological Chemistry. 280(29). 27251–27261. 124 indexed citations
9.
Royer, Yohan, Judith Staerk, Katharina F. Kubatzky, et al.. (2003). Active and Inactive Orientations of the Transmembrane and Cytosolic Domains of the Erythropoietin Receptor Dimer. Molecular Cell. 12(5). 1239–1250. 159 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026